Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: A 4-year follow-up study of a large screened cohort in Okinawa, Japan

Hypertension Research

Volumn 38, Issue 3, 2015, Pages 213-218

  Nagahama, Kazufumi ^a   Inoue, Taku ^b   Kohagura, Kentaro ^a   Kinjo, Kozen ^c   Ohya, Yusuke ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^c Okinawa General Health Maintenance Association   (Japan)

Author keywords

cardiovascular risk factors; cohort study; epidemiology; metabolic syndrome; uric acid

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHTHALIC ACID DIBUTYL ESTER; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERURICEMIA; INCIDENCE; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; LONGITUDINAL STUDY; MASS SCREENING; RISK FACTOR;

ADULT; BIOMARKERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; LONGITUDINAL STUDIES; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; URIC ACID;

EID: 84924421481     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2014.161     Document Type: Article

References (39)

1. Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. New Engl J Med 1966; 275: 457-464.
2. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, Davis CE, Heiss G. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population: Atherosclerosis Risk in Communities Study Investigators. Metabolism 1996; 45: 699-706.
3. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. New Engl J Med 2008; 359: 1811-1821.
4. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007; 120: 442-447.
5. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?Metabolism 2006; 55: 1293-1301.
6. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928-933.
7. Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 2004; 27: 227-233.
8. Nagahama K, Inoue T, Iseki K, Touma T, Kinjo K, Ohya Y, Takishita S. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res 2004; 27: 835-841.
9. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, Weiss ST, Litonjua AA. Uric acid and the development of hypertension-The Normative Aging Study. Hypertension 2006; 48: 1031-1036.
10. Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49: 298-303.
11. Nagahama K, Inoue T, Kohagura K, Ishihara A, Kinjo K, Ohya Y. Hyperuricemia predicts future metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. Hypertens Res 2014; 37: 232-238.
12. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008; 57: 845-852.
13. Hara S, Tsuji H, Ohmoto Y, Amakawa K, Hsieh SD, Arase Y, Nakajima H. High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population. Metabolism 2011; 24: 281-288.
14. Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, Chien KL, Hwang LC, Su TC, Tseng CH, Sun CA. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 2012; 220: 525-531.
15. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190.
16. Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 2013; 25: 210-216.
17. Edwards NL. The role of hyperuricemia in vascular disease. Curr Opin Rheumatol 2009; 21: 132-137.
18. So A, Thorens B. Uric acid transport and disease. J Clin Invest 2010; 120: 1791-1799.
19. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. New Engl J Med 1987; 317: 350-357.
20. Swislocki AL, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989; 2: 419-423.
21. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167-174.
22. Arcucci O, de Simone G, Izzo R, Rozza F, Chinali M, Rao MA, Bodenizza C, De Luca N, Trimarco B. Association of suboptimal blood pressure control with body size and metabolic abnormalities. J Hypertens 2007; 25: 2296-2300.
23. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, Arima H, Tsuryuya K, Iida M, Kiyohara Y. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke 2007; 38: 2063-2069.
24. Guideline Revising Committee of Japanese Society of Gout and Nucleic Acid Metabolism, ed. Revised Guideline for the Management of Hyperuriceima and Gout. Osaka: Medical Review Co Ltd 2010.
25. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
26. The Japanese Committee on the Criteria for MetS. Definition and the diagnostic standard for metabolic syndrome - Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nippon Naika Gakkai Zassi 2005; 94: 749-809.
27. Kahn R, Buse J, Ferrannini E, Stern M. American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304.
28. Vuorinen-Markkola H, Yki-Järvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25-29.
29. Modan M, Halkin H, Karasik A, Lusky A. Elevated serum uric acid-a facet of hyperinsulinaemia. Diabetologia 1987; 30: 713-718.
30. Reaven GM. The metabolic syndrome: time to get off the merry-go-round? J Intern Med 2011; 269: 127-136.
31. Bruce KD, Byrne CD. The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J 2009; 85: 614-621.
32. Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemol 2012; 176: 108-116.
33. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunciton. Kidney Int 2005; 67: 1739-1742.
34. Vasquez-Vivar J, Santos AM, Junqueria VB, Augusto O. Peroxynitrite-mediated formation of free radicals in human plasma: EPR detection of ascorbyl, albuminthiyl and uric acidderived free radicals. Biochem J 1996; 314: 869-876.
35. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 1989; 13: 859-864.
36. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000; 148: 131-139.
37. Nyyssonen K, Porkkala-Sarataho E, Kaikkonen J. Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finish men. Atherosclerosis 1997; 130: 223-233.
38. Yamamoto Y, Sonoyama K, Matsubara K, Furuse M, Yatsuhashi T, Hamada T, Ogino K, Igawa O, Hisatome I, Shigemasa C. The status of hypertension management in Japan in 2000. Hypertens Res 2002; 25: 717-725.
39. Yahyaoui R, Esteva I, Haro-Mora JJ, Almaraz MC, Morcillo S, Rojo-Marti'nez G, Marti'nez J, Go'mez-Zumaquero JM, Gonza'lez I, Hernando V, Soriguer F. Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons. J Clin Endocrinol Metab 2008; 93: 2230-2233.